| |
| |
|
| Insider
Information: |
Henner Dennis |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
4,233,397 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,544 |
|
|
| Total
Shares |
4,233,397 |
|
|
| Total
Value |
$1,544 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 12.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
Director |
2005-01-05 |
0 |
2005-01-05 |
0 |
Premium* |
|
|
Affymax Inc |
AFFY |
10% Owner |
|
0 |
2006-12-20 |
1,600,469 |
Premium* |
|
|
Humanigen Inc |
HGEN |
Director, 10% Owner |
2013-02-05 |
0 |
2013-02-05 |
2,632,928 |
Premium* |
|
|
Imago Biosciences, Inc. |
IMGO |
Director |
2023-01-11 |
0 |
2023-01-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AFFY |
Affymax Inc |
10% Owner |
– – • |
2006-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,248 |
|
- |
|
| AFFY |
Affymax Inc |
10% Owner |
– – • |
2006-12-19 |
4 |
D |
$25.00 |
$1,823,575 |
I/I |
(72,943) |
65,571 |
0 |
- |
|
| AFFY |
Affymax Inc |
10% Owner |
– – • |
2006-12-19 |
4 |
OE |
$17.00 |
$1,823,522 |
I/I |
107,266 |
138,514 |
0 |
- |
|
| AFFY |
Affymax Inc |
10% Owner |
– – • |
2006-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,534,898 |
1,600,469 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2003-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,340,278 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-02-19 |
4 |
S |
$20.00 |
$3,447,460 |
I/I |
(172,373) |
4,167,905 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-03-19 |
4 |
S |
$20.00 |
$346,680 |
I/I |
(17,334) |
4,150,571 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-04-08 |
4 |
S |
$19.93 |
$6,295,927 |
I/I |
(315,902) |
3,834,669 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-04-12 |
4 |
S |
$19.80 |
$7,920 |
I/I |
(400) |
3,834,269 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-04-19 |
4 |
S |
$20.30 |
$507,500 |
I/I |
(25,000) |
3,809,269 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-04-21 |
4 |
S |
$20.78 |
$2,778,605 |
I/I |
(133,698) |
3,675,571 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-05-20 |
4 |
S |
$17.25 |
$2,402,857 |
I/I |
(139,313) |
3,536,258 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-05-24 |
4 |
S |
$17.35 |
$57,255 |
I/I |
(3,300) |
3,532,958 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-05-26 |
4 |
S |
$17.80 |
$104,326 |
I/I |
(5,861) |
3,527,097 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-05-27 |
4 |
S |
$17.85 |
$359,672 |
I/I |
(20,154) |
3,506,943 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-05-28 |
4 |
S |
$18.00 |
$71,100 |
I/I |
(3,950) |
3,502,993 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-01 |
4 |
S |
$17.95 |
$179,500 |
I/I |
(10,000) |
3,492,993 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-02 |
4 |
S |
$18.00 |
$36,540 |
I/I |
(2,030) |
3,490,963 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-22 |
4 |
S |
$15.51 |
$462,153 |
I/I |
(29,805) |
3,461,158 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-23 |
4 |
S |
$15.50 |
$6,014 |
I/I |
(388) |
3,460,770 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-24 |
4 |
S |
$15.54 |
$1,084,850 |
I/I |
(69,807) |
3,390,963 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-25 |
4 |
S |
$15.80 |
$861,182 |
I/I |
(54,500) |
3,336,463 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,569 |
1,569 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,499,989) |
1,833,597 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-06-28 |
4 |
S |
$15.83 |
$45,545 |
I/I |
(2,877) |
3,333,586 |
|
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
